Eremina, Vera <br/><br/>
VEGF inhibition and renal thrombotic microangiopathy.  [electronic resource] 

 -  The New England journal of medicine  Mar 2008 
 - 1129-36 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa0707330  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--adverse effects<br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Female<br/>Gene Targeting<br/>Humans<br/>Kidney Glomerulus--blood supply<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Microcirculation--drug effects<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Podocytes--metabolism<br/>Proteinuria--chemically induced<br/>RNA, Messenger--metabolism<br/>Renal Circulation<br/>Signal Transduction<br/>Thrombosis--chemically induced<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors